TGTX Payables Turnover from 2010 to 2024
| TGTX Stock | USD 15.81 0.72 4.36% |
Payables Turnover | First Reported 2010-12-31 | Previous Quarter 0.37831094 | Current Value 0.36 | Quarterly Volatility 0.64319509 |
Check TG Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TG Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 433.5 K, Interest Expense of 13.2 M or Total Revenue of 245.3 M, as well as many indicators such as Price To Sales Ratio of 9.86, Dividend Yield of 4.0E-4 or PTB Ratio of 15.86. TGTX financial statements analysis is a perfect complement when working with TG Therapeutics Valuation or Volatility modules.
TGTX | Payables Turnover |
Latest TG Therapeutics' Payables Turnover Growth Pattern
Below is the plot of the Payables Turnover of TG Therapeutics over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. TG Therapeutics' Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TG Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Payables Turnover | 10 Years Trend |
|
Payables Turnover |
| Timeline |
TGTX Payables Turnover Regression Statistics
| Arithmetic Mean | 0.04 | |
| Coefficient Of Variation | 1,449 | |
| Mean Deviation | 0.29 | |
| Median | 0 | |
| Standard Deviation | 0.64 | |
| Sample Variance | 0.41 | |
| Range | 3.3287 | |
| R-Value | (0.33) | |
| Mean Square Error | 0.40 | |
| R-Squared | 0.11 | |
| Significance | 0.23 | |
| Slope | (0.05) | |
| Total Sum of Squares | 5.79 |
TGTX Payables Turnover History
About TG Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include TG Therapeutics income statement, its balance sheet, and the statement of cash flows. TG Therapeutics investors use historical funamental indicators, such as TG Therapeutics's Payables Turnover, to determine how well the company is positioned to perform in the future. Although TG Therapeutics investors may use each financial statement separately, they are all related. The changes in TG Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on TG Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on TG Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in TG Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Payables Turnover | 0.38 | 0.36 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for TGTX Stock Analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.